Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
|4||Not yet recruiting||
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
† Study has passed its completion date and status has not been verified in more than two years.